LOTTE Holdings Healthcare and Biopharmaceutical CVC Announces Investment in Alveus Therapeutics
TOKYO, JAPAN, March 19, 2026 /EINPresswire.com/ -- LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE Holdings”) announces an investment in Alveus Therapeutics, Inc. (hereinafter “Alveus Therapeutics”), a rapidly …